MDxHealth (MDXH) said Monday it expects Q4 revenue to increase by 28% year over year to about $24.7 million.
Five analysts polled by FactSet expect $23 million.
For 2024, the company also projected a 28% revenue growth to $90 million. Analysts surveyed by FactSet expect $87.9 million.
In addition, MDxHealth said it expects 2025 revenue growth of 20% to 22% to between $108 million and $110 million and reiterated its forecast of adjusted EBITDA profitability in H1.
Shares of MDxHealth were up more than 10% in recent premarket activity Monday.
Price: 2.18, Change: +0.20, Percent Change: +10.10
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。